On the public citation graph

New Biologic Drugs: Anti-Interleukin Therapy

0 signed · 79 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 76 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1096/fasebj.13.12.1575 (notice 2011-03-01).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archopht.123.7.957openalex-snapshot
Suppression of Immune-Mediated Ocular Inflammation in Mice by Interleukin 1 Receptor Antagonist Administration
inferredcites →https://doi.org/10.1001/archopht.1992.01080160125049openalex-snapshot
Activity of an Interleukin 1 Receptor Antagonist in Rabbit Models of Uveitis
inferredcites →https://doi.org/10.1001/archophthalmol.2007.49openalex-snapshot
Daclizumab for Treatment of Birdshot Chorioretinopathy
inferredcites →https://doi.org/10.1002/(sici)1097-4547(19970801)49:3<268::aid-jnr2>3.0.co;2-aopenalex-snapshot
Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: Comparison with vascular endothelial growth factor, tumor necrosis factor ?, and interleukin-1?-mediated breakdown
inferredcites →https://doi.org/10.1002/14651858.cd005121.pub3openalex-snapshot
Anakinra for rheumatoid arthritis
inferredcites →https://doi.org/10.1002/1521-4141(200001)30:1<272::aid-immu272>3.0.co;2-xopenalex-snapshot
Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis
inferredcites →https://doi.org/10.1002/art.20001openalex-snapshot
Treatment with a neutralizing anti‐murine interleukin‐17 antibody after the onset of collagen‐induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion
inferredcites →https://doi.org/10.1002/art.21249openalex-snapshot
Targeting interleukin‐15 in patients with rheumatoid arthritis: A proof‐of‐concept study
inferredcites →https://doi.org/10.1002/art.21675openalex-snapshot
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
inferredcites →https://doi.org/10.1002/art.23373openalex-snapshot
Successful treatment of a patient with takayasu arteritis using a humanized anti–interleukin‐6 receptor antibody
inferredcites →https://doi.org/10.1002/j.1460-2075.1994.tb06576.xopenalex-snapshot
Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15.
inferredcites →https://doi.org/10.1002/jlb.57.5.763openalex-snapshot
IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2
inferredcites →https://doi.org/10.1007/bf00417543openalex-snapshot
Endotoxin-induced uveitis in the rat
inferredcites →https://doi.org/10.1007/bf00810244openalex-snapshot
Immune mechanisms in uveitis
inferredcites →https://doi.org/10.1007/s000110050331openalex-snapshot
Interleukin-15 and its role in chronic inflammatory diseases
inferredcites →https://doi.org/10.1007/s12026-008-8031-3openalex-snapshot
Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells
inferredcites →https://doi.org/10.1016/0896-8411(90)90143-gopenalex-snapshot
Experimental autoimmune uveoretinitis in mice. induction by a single eliciting event and dependence on quantitative parameters of immunization
inferredcites →https://doi.org/10.1016/0896-8411(90)90144-hopenalex-snapshot
Pathology of experimental autoimmune uveoretinitis in mice
inferredcites →https://doi.org/10.1016/j.ajo.2009.06.003openalex-snapshot
High-dose Daclizumab for the Treatment of Juvenile Idiopathic Arthritis–Associated Active Anterior Uveitis
inferredcites →https://doi.org/10.1016/j.coph.2004.04.003openalex-snapshot
Interleukin-15: a new cytokine target for the treatment of inflammatory diseases
inferredcites →https://doi.org/10.1016/j.cyto.2008.12.019openalex-snapshot
Interleukin-17 causes neutrophil mediated inflammation in ovalbumin-induced uveitis in DO11.10 mice
inferredcites →https://doi.org/10.1016/j.immuni.2009.02.007openalex-snapshot
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
inferredcites →https://doi.org/10.1016/j.mehy.2008.01.011openalex-snapshot
Tocilizumab may be a potential addition to our weapons against neuro-Behçet’s disease
inferredcites →https://doi.org/10.1016/j.ophtha.2004.12.034openalex-snapshot
Initial Evaluation of Subcutaneous Daclizumab Treatments for Noninfectious UveitisA Multicenter Noncomparative Interventional Case Series
inferredcites →https://doi.org/10.1016/j.semarthrit.2010.05.008openalex-snapshot
Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis
inferredcites →https://doi.org/10.1016/j.yexcr.2011.02.017openalex-snapshot
Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis
inferredcites →https://doi.org/10.1016/s0002-9394(14)71071-2openalex-snapshot
Blood Serum Interleukin-1 Receptor Antagonist in Pars Planitis and Ocular Behçet Disease
inferredcites →https://doi.org/10.1016/s0161-6420(02)01932-2openalex-snapshot
Treatment of ocular inflammatory disorders with daclizumab
inferredcites →https://doi.org/10.1016/s1359-6101(02)00027-8openalex-snapshot
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
inferredcites →https://doi.org/10.1038/286611a0openalex-snapshot
Endotoxin-induced uveitis in rats as a model for human disease
inferredcites →https://doi.org/10.1038/nature04753openalex-snapshot
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
inferredcites →https://doi.org/10.1038/ncprheum0338openalex-snapshot
Interleukin 6: from bench to bedside
inferredcites →https://doi.org/10.1038/nm1097-1124openalex-snapshot
Interleukin-15 protects from lethal apoptosis in vivo
inferredcites →https://doi.org/10.1038/nm1585openalex-snapshot
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
inferredcites →https://doi.org/10.1056/nejmra041809openalex-snapshot
Anemia of Chronic Disease
inferredcites →https://doi.org/10.1073/pnas.0809850105openalex-snapshot
IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3 + regulatory T cells
inferredcites →https://doi.org/10.1073/pnas.96.13.7462openalex-snapshot
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial
inferredcites →https://doi.org/10.1080/09273940701299370openalex-snapshot
A Double-masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease
inferredcites →https://doi.org/10.1084/jem.160.4.1170openalex-snapshot
Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.
inferredcites →https://doi.org/10.1084/jem.180.4.1395openalex-snapshot
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
inferredcites →https://doi.org/10.1089/10979330152560478openalex-snapshot
Selective Loss of Viability of Mouse NK Cells in Culture is Associated with Decreased NK Cell Lytic Function
inferredcites →https://doi.org/10.1089/jop.1997.13.427openalex-snapshot
Antagonism of Interleukin-1 (IL-1)-Induced Uveitis with Synthetic IL-1 Blockers
inferredcites →https://doi.org/10.1089/jop.2000.16.407openalex-snapshot
Inhibition of Interleukin-1-Induced Uveitis and Corneal Fibroblast Proliferation by Interleukin-1 Blockers
inferredcites →https://doi.org/10.1093/rheumatology/ken489openalex-snapshot
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
inferredcites →https://doi.org/10.1096/fasebj.13.12.1575openalex-snapshot
Death deflected: IL‐15 inhibits TNF‐α‐mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL‐15Rα chain
inferredcites →https://doi.org/10.1097/bor.0b013e3283295fecopenalex-snapshot
Clinical value of blocking IL-6 receptor
inferredcites →https://doi.org/10.1097/icu.0b013e3282f03d42openalex-snapshot
Biologics in the treatment of uveitis
inferredcites →https://doi.org/10.1097/icu.0b013e32833f00b3openalex-snapshot
Future for biological therapy for uveitis
inferredcites →https://doi.org/10.1111/j.1365-3083.2006.01844.xopenalex-snapshot
Levels of IL‐15 in Serum and Cerebrospinal Fluid of Patients with Behçet's Disease
inferredcites →https://doi.org/10.1136/bjo.2006.0101477openalex-snapshot
Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome
inferredcites →https://doi.org/10.1136/bjo.2007.124081openalex-snapshot
Biological response modifier therapy for refractory childhood uveitis
inferredcites →https://doi.org/10.1167/iovs.07-1390openalex-snapshot
Upregulated IL-23 and IL-17 in Behcet Patients with Active Uveitis
inferredcites →https://doi.org/10.1167/iovs.10-6909openalex-snapshot
Understanding Autoimmune Uveitis through Animal Models The Friedenwald Lecture
inferredcites →https://doi.org/10.1186/ar2143openalex-snapshot
A pilot study of IL-1 inhibition by anakinra in acute gout
inferredcites →https://doi.org/10.1186/ar2477openalex-snapshot
TH-17 cells in rheumatoid arthritis
inferredcites →https://doi.org/10.1186/ar2680openalex-snapshot
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
inferredcites →https://doi.org/10.1186/ar2952openalex-snapshot
Mechanisms of inflammation in gout
inferredcites →https://doi.org/10.1517/14712598.2012.658366openalex-snapshot
Biological agents for the treatment of uveitis
inferredcites →https://doi.org/10.1517/14712598.8.5.669openalex-snapshot
The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis
inferredcites →https://doi.org/10.1586/eci.10.41openalex-snapshot
Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis
inferredcites →https://doi.org/10.2147/ce.s5992openalex-snapshot
Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis
inferredcites →https://doi.org/10.2353/ajpath.2008.070690openalex-snapshot
Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
inferredcites →https://doi.org/10.3109/02713689008999424openalex-snapshot
Comparison of clinical and experimental uveitis
inferredcites →https://doi.org/10.3109/02713689008999438openalex-snapshot
The mouse as a model of experimental autoimmune uveoretinitis (EAU)
inferredcites →https://doi.org/10.3109/02713689208999531openalex-snapshot
Cytokines in human intraocular inflammation
inferredcites →https://doi.org/10.3121/cmr.4.4.294openalex-snapshot
Cytokines and Chemokines in Uveitis - Is there a Correlation with Clinical Phenotype?
inferredcites →https://doi.org/10.3899/jrheum.090074openalex-snapshot
Anakinra for Rheumatoid Arthritis: A Systematic Review
inferredcites →https://doi.org/10.4049/jimmunol.136.3.928openalex-snapshot
T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat.
inferredcites →https://doi.org/10.4049/jimmunol.154.2.483openalex-snapshot
IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation.
inferredcites →https://doi.org/10.4049/jimmunol.156.2.735openalex-snapshot
Induction and regulation of IL-15 expression in murine macrophages
inferredcites →https://doi.org/10.4049/jimmunol.156.4.1654openalex-snapshot
Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice
inferredcites →https://doi.org/10.4049/jimmunol.158.1.452openalex-snapshot
Humanized antibodies against the α-chain of the IL-2 receptor and against the β-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases
inferredcites →https://doi.org/10.4049/jimmunol.164.3.1185openalex-snapshot
Analysis of Immunomodulatory Activities of Aqueous Humor from Eyes of Mice with Experimental Autoimmune Uveitis
inferredcites →https://doi.org/10.4049/jimmunol.167.6.3129openalex-snapshot
Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15
inferredcites →https://doi.org/10.4321/s0365-66912004001200004openalex-snapshot
Uveítis recurrentes y tratamiento con anticuerpos monoclonales (Daclizumab)
inferredcites →https://doi.org/10.4414/smw.2011.13156openalex-snapshot
Rapid induction of remission in large vessel vasculitis by IL-6 blockade

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4866588openalex-extracted
The Pathogenesis of Rheumatoid Arthritis Associated Interstitial Lung Disease and the Progress in the Treatment of Traditional Chinese Medicine
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2019.13102openalex-snapshot
Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors
inferred← citeshttps://doi.org/10.62587/afrjbs.1.2.2024.72-88openalex-snapshot
From the double helix to precision genomics: A comprehensive review of DNA and its transformative role in biomedical sciences
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.